Publication at First Faculty of Medicine |
2010
Abstract
The use of a panel of anticarbohydrate antibodies may provide additional help in distinguishing IBD from non-IBD disease patterns. The addition of AMCA, ALCA, and ACCA assays as IBD serology markers improves the overall sensitivity of immunological examinations in IBD; however, anticarbohydrate assays are not helpful for predicting CD behavior.
Keywords
antichitobioside carbohydrate antibodies antilaminaribioside carbohydrate antibodies antimannobioside carbohydrate antibodies anti-Saccharomyces cerevisiae antibodies Crohn's disease inflammatory bowel disease ulcerative colitis crohn's disease serological markers microbial antigens prognosis behavior ibd